Evaluation of the clot signature analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin

Clinical and Applied Thrombosis/Hemostasis

Volumn 5, Issue 2, 1999, Pages 117-121

  Igawa, Takehiro ^a   Kornhauser, Robyn ^a   Cilla, Donald D ^a   King, Jennifer O'Neal ^a   Kambayashi, Junichi ^a  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Bleeding time; Clot Signature Analyzer (CSA); Collagen induced thrombus formation (CITF); Platelet aggregation; Platelet hemostasis time (PHT)

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VALIDATION PROCESS;

EID: 0032918937     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969900500208     Document Type: Article

References (19)

1. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH Report. Sub-committee on rheology of the international committee on thrombosis and haemostasis. Thromb Haemost 1986;55:415.
2. Buchanan GR, Christine A, Holtkamp MT. A comparative study of variables affecting the bleeding time using two disposable devices. Am J Clin Pathol 1989;91:45.
3. Koster T, Caekebeke-Peerlinek KMJ, Briet E. A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniques. Am J Clin Pathol. 1989;92:315.
4. Marshall PW, Williams AJ, Dixon RM, et al. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997;44:151.
5. Kovacs IB, Hutton RA, Kernoff PBA. Hemostatic evaluation in bleeding disorders from native blood: clinical experience with the Haemostatometer. Am J Clin Pathol 1989;91:271.
6. Muga KM, Melton LG, Gabriel DA. A flow dynamic technique used to assess global haemostasis. Blood Coagul Fibrinolysis 1995;6:73.
7. Roger SD, Piper J, Tucker R, et al. Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry. Nephron 1992;62:422.
8. Martin C. Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin/thromboxane ratios in late pregnancy. Prostaglandins 1996;51:321.
9. Schror K. Aspirin and platelets: the antiplatelet action of aspirin nd its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997;23:349.
10. Hoak JC. Mechanisms of action: aspirin. Thromb Res 1983;4 (suppl):47.
11. Gorog P, Kovacs IB. Coagulation of flowing native blood: advantages over stagnant (tube) clotting tests. Thromb Res 1991;64:611.
12. Kovacs IB, Gorog P. Simultaneous measurement of all thrombosis parameter from native human blood: usefulness in monitoring efficacy and complications of thrombolytic therapy. Angiology 1990;41:829.
13. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178.
14. 2 and prostacyclin. Stroke 1992;23:1400.
15. 2 in whole blood after aspirin administration in human subjects. J Am Coll Cardial 1984; 4:806.
16. Orlikowski CE, Rocke DA. The effect of low dose aspirin on bleeding times. Anaesthesia 1993;8:915.
17. Rumore MM, Aron SM, Hiross EJA. Review of mechanism of action of aspirin and its potential as an immunomodulating agent. Med Hypotheses 1987;22:387.
18. Ghooi RB, Thatte SM, Joshi PS. The mechanism of action of aspirin - is there anything beyond cyclo-oxygenase? Med Hypotheses 1995;44:77.
19. Nemerson Y, Turitto VT. The effect of flow on hemostasis and thrombosis. Thromb Haemost 1991;66:272.